{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:46:55Z","timestamp":1772696815624,"version":"3.50.1"},"reference-count":80,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,22]]},"DOI":"10.18632\/oncotarget.7396","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T15:42:37Z","timestamp":1455550957000},"page":"14551-14568","source":"Crossref","is-referenced-by-count":42,"title":["Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade"],"prefix":"10.18632","volume":"7","author":[{"given":"Melissa","family":"Schmidt","sequence":"first","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mock","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Jungk","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Heidelberg University Hospital, CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Theresa","family":"Ull","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Warta","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Lamszus","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Gousias","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ketter","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saarland University, Medical School, Homburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Roesch","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rapp","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Schefzyk","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Heidelberg University Hospital, CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffi","family":"Urbschat","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saarland University, Medical School, Homburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Lahrmann","sequence":"additional","affiliation":[{"name":"Bioquant, Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almuth F.","family":"Kessler","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"L\u00f6hr","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Senft","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Frankfurt, Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Grabe","sequence":"additional","affiliation":[{"name":"Bioquant, Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reuss","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Heidelberg University Hospital, CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Beckhove","sequence":"additional","affiliation":[{"name":"Regensburg Center for Interventional Immunology, RCI and University Medical Center of Regensburg, Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Westphal","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Heidelberg University Hospital, CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Unterberg","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Herold-Mende","sequence":"additional","affiliation":[{"name":"Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16","author":"Barnholtz-Sloan","year":"2014","journal-title":"Neuro-oncology"},{"key":"2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Kleihues","year":"2007","journal-title":"Acta Neuropathol"},{"key":"3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Perry","year":"2010","journal-title":"J Neurooncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Reifenberger","year":"2006","journal-title":"Lancet Neurol"},{"key":"5","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M","article-title":"\u2018Malignancy\u2019 in meningiomas: a clinicopathologic study of 116 patients, with grading implications","volume":"85","author":"Wollan","year":"1999","journal-title":"Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","article-title":"Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features","volume":"79","author":"Jung","year":"2008","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1586\/14737175.4.4.641","article-title":"Intracranial meningiomas: diagnosis and treatment","volume":"4","author":"Blumenthal","year":"2004","journal-title":"Expert Rev Neurother"},{"key":"8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"SIMPSON","year":"1957","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3171\/2012.3.JNS111945","article-title":"Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas","volume":"117","author":"Saito","year":"2012","journal-title":"J Neurosurg"},{"key":"10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","article-title":"Meningioma grading: an analysis of histologic parameters","volume":"21","author":"Lohse","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"Witteveen","year":"2002","journal-title":"N Engl J Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Wu","year":"2013","journal-title":"Cell"},{"key":"13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/ijc.22855","article-title":"Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas","volume":"121","author":"Rahnenf\u00fchrer","year":"2007","journal-title":"Int J Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2011.2.FOCUS1116","article-title":"The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments","volume":"30","author":"Yang","year":"2011","journal-title":"Neurosurg Focus"},{"key":"15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas","volume":"6","author":"Collins","year":"1994","journal-title":"Nat Genet"},{"key":"16","first-page":"4696","article-title":"Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression","volume":"55","author":"Menon","year":"1995","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-4608(98)00209-X","article-title":"Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas","volume":"110","author":"Westphal","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1750-3639.2002.tb00429.x","article-title":"Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas","volume":"12","author":"Collins","year":"2002","journal-title":"Brain Pathol"},{"key":"19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Macconaill","year":"2013","journal-title":"Nat Genet"},{"key":"20","article-title":"Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO","author":"Carri\u00f3n-Grant","year":"2013","journal-title":"Science"},{"key":"21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","author":"Capper","year":"2013","journal-title":"Acta Neuropathol"},{"key":"22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-013-1187-5","article-title":"AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry","volume":"126","author":"Brehmer","year":"2013","journal-title":"Acta Neuropathol"},{"key":"23","first-page":"1395","article-title":"Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype","volume":"35","author":"Jouvet","year":"2009","journal-title":"Int J Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/NEN.0b013e31826bf704","article-title":"Genetic alterations associated with progression and recurrence in meningiomas","volume":"71","author":"Mel\u00e9ndez","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/neuonc\/noq081","article-title":"Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas","volume":"12","author":"Mel\u00e9ndez","year":"2010","journal-title":"Neuro-oncology"},{"key":"26","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","article-title":"Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma","volume":"65","author":"Perry","year":"2005","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1634\/theoncologist.2010-0249","article-title":"DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence","volume":"16","author":"Pollo","year":"2011","journal-title":"Oncologist"},{"key":"28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3182018f1c","article-title":"Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays","volume":"70","author":"Gutmann","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/cncr.22130","article-title":"Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9","volume":"107","author":"Deimling von","year":"2006","journal-title":"Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1073\/pnas.89.7.3010","article-title":"Analysis of gene expression in single live neurons","volume":"89","author":"Coleman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy--analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Irizarry","year":"2004","journal-title":"Bioinformatics"},{"key":"32","first-page":"research0048","article-title":"A new non-linear normalization method for reducing variability in DNA microarray experiments","volume":"3","author":"Knudsen","year":"2002","journal-title":"Genome Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccr.2006.11.023","article-title":"High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene","volume":"11","author":"Seoane","year":"2007","journal-title":"Cancer Cell"},{"key":"34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bpa.12174","article-title":"Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma","volume":"25","author":"Aldape","year":"2015","journal-title":"Brain Pathol"},{"key":"35","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Tibshirani","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10637-013-0050-9","article-title":"Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed\/refractory multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"32","author":"Iyer","year":"2014","journal-title":"Invest New Drugs"},{"key":"37","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1158\/1078-0432.CCR-12-0571","article-title":"Phase I pharmacokinetic\/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors","volume":"18","author":"Ma\u00f1os","year":"2012","journal-title":"Clin Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1158\/1078-0432.CCR-11-3251","article-title":"Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study","volume":"18","author":"Blaney","year":"2012","journal-title":"Clin Cancer Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.2012.46.8793","article-title":"Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas","volume":"32","author":"Bernstein","year":"2014","journal-title":"J Clin Oncol"},{"key":"40","first-page":"1377","article-title":"Aurora kinase A inhibitors: promising agents in antitumoral therapy","volume":"18","author":"P\u00e9rez de Castro","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"41","first-page":"170","article-title":"Prognostic significance of Ki-67\/MIB-1 proliferation index in meningiomas","volume":"24","author":"Sundstr\u00f8m","year":"2005","journal-title":"Clin Neuropathol"},{"key":"42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1309\/HXUNAG34B3CEFDU8","article-title":"Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas","volume":"128","author":"Feiden","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"43","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2013.10.FOCUS13360","article-title":"A review of epigenetic and gene expression alterations associated with intracranial meningiomas","volume":"35","author":"Mack","year":"2013","journal-title":"Neurosurg Focus"},{"key":"44","doi-asserted-by":"crossref","first-page":"e67291","DOI":"10.1371\/journal.pone.0067291","article-title":"Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma","volume":"8","author":"Monleon","year":"2013","journal-title":"PLoS ONE"},{"key":"45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Williams","year":"2000","journal-title":"Nature"},{"key":"46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Lander","year":"1999","journal-title":"Science"},{"key":"47","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Delwel","year":"2004","journal-title":"N Engl J Med"},{"key":"48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Pollack","year":"2004","journal-title":"N Engl J Med"},{"key":"49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1200\/JCO.2007.14.3222","article-title":"Clinical application of the 70-gene profile: the MINDACT trial","volume":"26","author":"Piccart-Gebhart","year":"2008","journal-title":"J Clin Oncol"},{"key":"50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-6-64","article-title":"Molecular signatures define two main classes of meningiomas","volume":"6","author":"Lal","year":"2007","journal-title":"Mol Cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"e52707","DOI":"10.1371\/journal.pone.0052707","article-title":"Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum","volume":"7","author":"Mao","year":"2012","journal-title":"PLoS ONE"},{"key":"52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.20733","article-title":"Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression","volume":"114","author":"Lichter","year":"2005","journal-title":"Int J Cancer"},{"key":"53","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2013.10.FOCUS13326","article-title":"Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas","volume":"35","author":"Mack","year":"2013","journal-title":"Neurosurg Focus"},{"key":"54","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/oby.2002.127","article-title":"Leptin production by the stomach is up-regulated in obese (fa\/fa) Zucker rats","volume":"10","author":"Palou","year":"2002","journal-title":"Obes Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00041552-200403000-00010","article-title":"Leptin, obesity and cardiovascular disease","volume":"13","author":"Haynes","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"56","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/oby.20492","article-title":"Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity","volume":"22","author":"Chung","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"57","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ana.410200326","article-title":"Meningiomas and obesity reconsidered","volume":"20","author":"Holmes","year":"1986","journal-title":"Ann Neurol"},{"key":"58","first-page":"236","article-title":"Increased prevalence of obesity and obesity-related postoperative complications in male meningioma patients","volume":"54","author":"Barker","year":"2007","journal-title":"Clin Neurosurg"},{"key":"59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cdp.2005.07.002","article-title":"Predisposing conditions and risk factors for development of symptomatic meningioma in adults","volume":"29","author":"Rainov","year":"2005","journal-title":"Cancer Detect Prev"},{"key":"60","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1074\/jbc.M009654200","article-title":"Identification of c-myc as a down-stream target for pituitary tumor-transforming gene","volume":"276","author":"Pei","year":"2001","journal-title":"J Biol Chem"},{"key":"61","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.21137","article-title":"Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo","volume":"43","author":"Im","year":"2006","journal-title":"Hepatology"},{"key":"62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-4598-4-3","article-title":"Ectopic expression of PTTG1\/securin promotes tumorigenesis in human embryonic kidney cells","volume":"4","author":"Kakar","year":"2005","journal-title":"Mol Cancer"},{"key":"63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-4598-5-61","article-title":"Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2)","volume":"5","author":"Kakar","year":"2006","journal-title":"Mol Cancer"},{"key":"64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1385\/EP:17:2:143","article-title":"PTTG overexpression is correlated with angiogenesis in human pituitary adenomas","volume":"17","author":"Osamura","year":"2006","journal-title":"Endocr Pathol"},{"key":"65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clineuro.2014.04.028","article-title":"Characterization of pituitary tumor transforming gene in meningiomas","volume":"122","author":"Kwan","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"66","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/mend.13.1.0225","article-title":"Structure, expression, and function of human pituitary tumor-transforming gene (PTTG)","volume":"13","author":"Melmed","year":"1999","journal-title":"Mol Endocrinol"},{"key":"67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jjco\/hyf058","article-title":"Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer","volume":"32","author":"Terashita","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.acthis.2013.09.011","article-title":"Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma","volume":"116","author":"Ma","year":"2014","journal-title":"Acta Histochem"},{"key":"69","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.21181","article-title":"Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis","volume":"43","author":"Nakao","year":"2006","journal-title":"Hepatology"},{"key":"70","first-page":"1569","article-title":"Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients","volume":"15","author":"Yamanaka","year":"2006","journal-title":"Oncol Rep"},{"key":"71","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1158\/0008-5472.CAN-11-2330","article-title":"Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma","volume":"72","author":"Teh","year":"2012","journal-title":"Cancer Res"},{"key":"72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2014.14","article-title":"The aurora kinases in cell cycle and leukemia","volume":"34","author":"Crispino","year":"2015","journal-title":"Oncogene"},{"key":"73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1440-1789.2012.01338.x","article-title":"Molecular characterization of central neurocytomas: potential markers for tumor typing and progression","volume":"33","author":"F\u00e8vre-Montange","year":"2013","journal-title":"Neuropathology"},{"key":"74","first-page":"1093","article-title":"Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients","volume":"16","author":"Yamanaka","year":"2006","journal-title":"Oncol Rep"},{"key":"75","first-page":"533","article-title":"Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer","volume":"7","author":"Zheng","year":"2008","journal-title":"HBPD INT"},{"key":"76","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1074\/jbc.M306725200","article-title":"Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation","volume":"279","author":"Miki","year":"2004","journal-title":"J Biol Chem"},{"key":"77","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.surg.2013.06.058","article-title":"PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target","volume":"154","author":"Bussey","year":"2013","journal-title":"Surgery"},{"key":"78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jso.22141","article-title":"A study of UbcH10 expression and its association with recurrence of meningiomas","volume":"106","author":"Lu","year":"2012","journal-title":"J Surg Oncol"},{"key":"79","first-page":"1521","article-title":"Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma","volume":"10","author":"Kley","year":"1995","journal-title":"Oncogene"},{"key":"80","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1586\/ern.12.108","article-title":"Chemotherapy: What is its role in meningioma?","volume":"12","author":"Raizer","year":"2012","journal-title":"Expert Rev Neurother"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:04:29Z","timestamp":1718363069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,15]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3,22]]}},"alternative-id":["7396","26894859"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7396","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,15]]}}}